ISIN and CFI Database for Non-Russian Financial Instruments that Meet the Requirements of Bank of Russia Regulation on Qualification
The Database contains ISIN and CFI codes allocated by authorized agencies in accordance with ISO 6166 and ISO 10962, and the CFI codes meet the requirements of paragraph 4.2 of the Directive of the Central Bank of the Russian Federation No. 4561-U dated October 3, 2017 "On the Procedure for the Qualification of Foreign Financial Instruments as Securities" (in the version of the Directive of Bank of Russia No. 4903-U dated 12.09.2018).
Information on non-Russian financial instruments is updated in real time as a result of processing clients' new requests relating to new instruments, and upon completion of NSD's daily monitoring of information on instruments already recorded in the Database.
Information on ISIN and CFI codes is provided by NSD to market participants solely for the purpose of qualification of non-Russian financial instruments as securities admitted for operations on the Russian market*.
28681-28700 of 80004 results shown.
New – ISIN first sent in ASB database;
Updated – One of the fields of the ISIN record is updated;
Deleted – The instrument associated with the ISIN is not active anymore (for example, the instrument has expired/matured or went bankrupt, if it was an equity);
Reused - The information of a new instrument with an already existing ISIN first sent in the ASB database.
ISIN |
Issuer; Country |
Issue Description |
CFI Code |
Edition of IS0 10962 |
ISIN Status [?] |
Numbering Agency |
Information Source |
As of |
US09072V5012 |
BIOCEPT INC; US |
COM PAR $0.0001 NEW |
ESVUPR |
2015 | Deleted |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2023-05-18 |
US09072V6002 |
BIOCEPT INC; US |
COM PAR $0.0001 NEW 2023 |
ESVUFR |
2015 | Updated |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2023-07-07 |
US09072X1019 |
BIOPHARMX CORP; US |
COM |
ESVUFR |
2015 | Deleted |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2021-11-26 |
US09072X3098 |
BIOPHARMX CORP; US |
COM NEW |
ESVUFR |
2015 | Deleted |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2021-11-26 |
US09073M1045 |
BIO-TECHNE CORP; US |
COM |
ESVUFR |
2015 | Updated |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2021-11-26 |
US09073N2018 |
BIOSIG TECHNOLOGIES INC; US |
COM NEW |
ESVUFR |
2015 | Updated |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2021-09-28 |
US09073N3008 |
BIOSIG TECHNOLOGIES INC; US |
COM PAR $0.001 |
ESVUFR |
2015 | New |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASB |
2024-02-06 |
US09073Q1058 |
SCINAI IMMUNOTHERAPEUTICS LTD; IL |
SPONSORED ADS REPSTG ORD SHS |
EDSXFR |
2015 | Deleted |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2023-09-02 |
US09073Q2049 |
SCINAI IMMUNOTHERAPEUTICS LTD; IL |
SPONSORED ADR NEW |
EDSXDR |
2015 | Updated |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2023-09-02 |
US09074B1070 |
RENOVARE ENVIRONMENTAL INC; US |
COM |
ESVUFR |
2015 | Updated |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2021-12-08 |
US09074F2074 |
BIOVIE INC; US |
CL A NEW |
ESVUFR |
2015 | Updated |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2021-11-26 |
US09074M1036 |
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC; US |
COM |
ESVUFR |
2015 | Deleted |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2023-07-21 |
US09075A1088 |
BIOVENTUS INC; US |
CL A |
ESVUFR |
2015 | Updated |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASB |
2021-12-13 |
US09075E1001 |
BIOVERATIV INC; US |
COM |
ESVUFR |
2015 | Deleted |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2021-11-26 |
US09075F1075 |
BIONANO GENOMICS INC; US |
COM |
ESVUFR |
2015 | Deleted |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2023-08-10 |
US09075F3055 |
BIONANO GENOMICS INC; US |
COM NEW |
ESVUFR |
2015 | Updated |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2023-10-04 |
US09075P1057 |
BIOXCEL THERAPEUTICS INC; US |
COM |
ESVUFR |
2015 | Updated |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASB |
2022-05-19 |
US09075V1026 |
BIONTECH SE; DE |
ADS |
EDSXDR |
2015 | Updated |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2023-01-10 |
US09075X1081 |
BIODESIX INC; US |
COM |
ESVUFR |
2015 | Updated |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2023-01-10 |
US09076G1040 |
BIOPHYTIS SA; FR |
ADR |
EDSXFR |
2015 | Deleted |
Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES |
ASBF |
2023-03-31 |
* NSD does not make any representation or warranty as to the completeness or reliability of the information contained herein, nor does it make any warranty regarding its consistency with the purposes for which the information is used, including but not limited to, commercial purposes.
The information published on this website is not to be construed as an offer to effect any deal with financial instruments, and should not be used for commercial or other purposes; nor does it represent an offer from NSD to render any services; nor does it make any warranty or representation of reliability of certain financial instruments or persons (including but not limited to, issuers, securities market participants, etc.).
For further information, please refer to NSD’s experts.
|